Regulation of 17-beta hydroxysteroid dehydrogenase type 2 in human placental endothelial cells

Biology of Reproduction

Volumn 77, Issue 3, 2007, Pages 517-525

  Su, Emily J ^a   Cheng, You Hong ^b   Chatterton, Robert T ^a,b   Lin, Zhi Hong ^b   Yin, Ping ^b   Reierstad, Scott ^b   Innes, Joy ^b   Bulun, Serdar E ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Placenta; Pregnancy; Steroid hormone receptors; Steroid hormones

Indexed keywords

ESTRADIOL; MESSENGER RNA; PROGESTERONE; PROMEGESTONE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE TYPE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TIME;

17-HYDROXYSTEROID DEHYDROGENASES; ENDOTHELIAL CELLS; ESTRADIOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOBLOTTING; PLACENTA; PROGESTERONE; PROGESTERONE CONGENERS; PROMEGESTONE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER;

EID: 34548274878     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.059451     Document Type: Article

References (50)

1. Andersson S, Mogrhabi N. Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 1997; 62:143-147.
2. Mindnich R, Möller G, Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2004; 15:7-20.
3. Beaudoin C, Blomquist CH, Tremblay Y. Gene expression of 17 beta-hydroxysteroid dehydrogenase type 2 isozyme in primary cultures of human trophoblasts predicts different mechanisms regulating type 1 and type 2 enzymes. Endocrinology 1995; 136:3807-3814.
4. Moghrabi N, Head JR, Andersson S. Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocrinol Metab 1997; 82:3872-3878.
5. Takeyama J, Sasano H, Suzuki T, Iinuma K, Nagura H, Andersson S. 17 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta: an immunohistochemical study with correlation to placental development. J Clin Endocrinol Metab 1998; 83:3710-3715.
6. Bonenfant M, Blomquist CH, Provost PR, Drolet R, D'Ascoli P, Tremblay Y. Tissue- and site-specific gene expression of type 2 17 beta-hydroxysteroid dehydrogenase: in situ hybridization and specific enzymatic activity studies in human placental endothelial cells of the arterial system. J Clin Endocrinol Metab 2000; 85:4841-4850.
7. Siiteri PK, MacDonald PC. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966; 26:751-761.
8. Ryan KJ. Metabolism of C16-oxygenated steroids by human placenta: the formation of estriol. J Biol Chem 1957; 234:2006-2008.
9. Gurpide E, Mars C, deZiegler D, Berk PD, Brandes JM. Asymmetric release of estrone and estradiol derived from labeled precursors in perfused human placentas. Am J Obstet Gynecol 1982; 144:551-555.
10. Walsh SW, McCarthy MS. Selective placental secretion of estrogens into fetal and maternal circulations. Endocrinology 1981; 109:2152-2159.
11. Casey ML, MacDonald PC, Andersson S. 17 beta-hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 1994; 94:2135-2141.
12. Yang S, Fang Z, Gurates B, Tamura M, Miller J, Ferrer K, Bulun SE. Stromal PRs mediate induction of 17 beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. Mol Endocrinol 2001; 15:2093-2105.
13. Ito K, Suzuki Ta, Moriya T, Utsunomiya H, Sugawara A, Konno R, Sato S, Sasano H. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 2001; 86:2721-2727.
14. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 1994; 15:61-79.
15. Evans TRJ, Kaye SB. Retinoids: present role and future potential. Br J Cancer 1999; 80:1-8.
16. Reed MJ, Rea D, Duncan LJ, Parker MG. Regulation of estradiol 17 beta-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast caner cells. Endocrinology 1994; 135:4-9.
17. Fukunaka K, Saito T, Wataba K, Ashihara K, Ito E, Kudo R. Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle. Mol Hum Reprod 2001; 7:437-446.
18. Stephanou A, Handwerger S. Retinoic acid and thyroid hormone regulate placental lactogen expression in human trophoblast cells. Endocrinology 1995; 136:933-938.
19. Guibordenche J, Alsat E, Soncin F, Rochette-Egly C, Evain-Brion D. Retinoic receptors expression in human term placenta: involvement of RXR alpha in retinoic-induced hCG secretion. J Clin Endocrinol Metab 1998; 83:1384-1387.
20. Zhu SJ, Li Y, Li H, Wang YL, Xiao ZJ, Vihko P, Piao YS. Retinoic acids promote the action of aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17 beta-estradiol in placental cells. J Endocrinol 2002; 172:31-43.
21. Cho SJ, George CL, Snyder JM, Acarrequi MJ. Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor. Am J Respir Cell Mol Biol 2005; 33:622-628.
22. Jinga VV, Gafencu A, Antohe F, Constantinescu E, Heltianu C, Raicu M, Manolescu I, Hunziker W, Simionescu M. Establishment of a pure vascular endothelial cell line from human placenta. Placenta 2000; 21:325-336.
23. Lang I, Pabst MA, Hiden U, Blaschitz A, Dohr G, Hahn T, Desoye G. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur J Cell Biol 2003; 82:163-173.
24. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337:1584-1590.
25. St. Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lai A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. Genes expressed in human tumor endothelium. Science 2000; 289:1197-1202.
26. Maldonado-Estrado J, Menu E, Roques P, Barre-Sinnousi F, Chaouat G. Evaluation of cytokeratin-7 as an accurate intracellular marker with which to assess the purity of human placental villous trophoblast cells by flow cytometery. J Immunol Methods 2004; 286:21-34.
27. Serrano MA, Macias RIR, Briz O, Monte MJ, Blazquez AG, Williamson C, Kubitz R, Marin JJG. Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3, and Jar of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 2007; 28:107-117.
28. Cattoretti G, Schiro R, Orazi A, Soligo D, Colombo MP. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993; 81:1726-1738.
29. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J Biol Chem 1993; 268:12964-12969.
30. Giguere V, Ong ES, Segui P, Evans RM. Identification of a receptor for the morphagen retinoic acid. Nature 1987; 330:624-629.
31. Manglesdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345:224-229.
32. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 2004; 64:1522-1533.
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 2001; 25:402-408.
34. Ringler GE, Strauss JF III. In vitro systems for the study of human placental endocrine function. Endocr Rev 1990; 11:105-123.
35. Mustonen MVJ, Isomaa VV, Vaskivuo T, Tapanainen J, Poutanen MH, Stenback F, Vihko RJ, Vihko PT. Human 17 beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle. J Clin Endocrinol Metab 1998; 83:1319-1324.
36. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance in male and female offspring. Am J Obstet Gynecol 1982; 142:905-921.
37. Potischman N, Troisi R. In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control 1999; 10:561-573.
38. Troisi R, Potischman N, Roberts JM, Harger G, Markovic N, Cole B, Lykins D, Siiteri P, Hoover RN. Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev 2003; 12:452-456.
39. Cunningham FG, Leveno KL, Bloom SL, Hauth JC, Gilstrap JC, Wenstrom K (eds.). Williams Obstetrics. New York: McGraw-Hill; 2005.
40. Gurpide E, Mars C, deZiegler D, Berk PD, Brandes JM. Asymmetric release of estrone and estradiol derived from labeled precursors in perfused human placentas. Am J Obstet Gynecol 1982; 144:551-555.
41. Walsh SW, McCarthy MS. Selective placental secretion of estrogens into fetal and maternal circulations. Endocrinology 1981; 109:2152-2159.
42. Zile MH. Vitamin A and embryonic development: an overview. J Nutr 1998; 128(suppl):455S-458S.
43. Sapin V, Dolle P, Hindelang C, Kastner P, Chambon P. Defects of the chorioallantoic placenta in mouse RXR alpha null fetuses. Dev Biol 1997; 191:29-41.
44. Manglesdorf DJ. Vitamin A receptors. Nutr Rev 1994; 52:S32-S44.
45. Napoli JL. Biochemical pathways of retinoic transport, metabolism, and signal transduction. Clin Immunol Immunopathol 1996; 80:S62-S62.
46. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10:940-954.
47. Baxevanis AD (ed.). Current Protocols in Bioinformatics. Hoboken, NJ: John Wiley and Sons, Inc.; 2006.
48. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor SP1 and functional analysis of the DNA binding domain. Cell 1987; 51:1079-1090.
49. Courey AJ, Holtzman DA, Jackson SP, Tjian R. Synergistic activation by the glutamine-rich domains of human transcription factor SP1. Cell 1989; 59:827-836.
50. Cheng YH, Imir A, Suzuki T, Fenkci V, Yilmaz B, Sasano H, Bulun SE. SP1 and SP3 mediate progesterone-dependent induction of the 17-beta hydroxysteroid dehydrogenase type 2 (HSD17B2) gene in human endometrium. Biol Reprod 2006; 75:605-614.